Literature DB >> 24942573

Comparative analysis of the capacity of elite suppressor CD4+ and CD8+ T cells to inhibit HIV-1 replication in monocyte-derived macrophages.

Victoria E K Walker-Sperling1, Robert W Buckheit1, Joel N Blankson2.   

Abstract

UNLABELLED: Elite controllers or suppressors (ESs) are HIV-1-infected individuals who are able to maintain viral loads below the limit of detection of clinical assays without antiretroviral therapy. The mechanisms of virologic control are not fully understood, but ESs have been shown to have a more effective CD8+ T cell response to infected CD4+ T cells than chronic progressors (CPs). While macrophages are another cell type productively infected by HIV-1, few studies have examined the ability of primary effector T cells to suppress HIV-1 replication in these target cells. Here, we compared the ability of unstimulated primary CD4+ and CD8+ effector T cells to suppress viral replication in monocyte-derived macrophages (MDMs) in ESs and CPs. While CD4+ effector T cells were capable of inhibiting viral replication in MDMs, the magnitude of this response was not significantly different between ESs and CPs. In contrast, the CD8+ T cells from ESs were significantly more effective than those from CPs at inhibiting viral replication in MDMs. The CD4+ T cell response was partially mediated by soluble factors, while the CD8+ T cell response required cell-to-cell interaction. Our results suggest that the individual contributions of various effector cells should be considered in rational vaccine design and in ongoing eradication efforts. IMPORTANCE: Elite suppressors are individuals capable of maintaining low-level viremia in HIV-1 infection without antiretroviral drugs. Their T cell responses have been implicated in eliminating infected CD4+ T cells, and as such, elite suppressors may represent a model of a functional cure of HIV-1 infection. Here, we sought to determine whether the suppressive T cell responses against infected CD4+ T cells also apply to infected macrophages by comparing the responses of elite suppressors and HIV-1-positive individuals on highly active antiretroviral therapy (HAART). Our results show that the CD8+ cells but not CD4+ T cells from elite suppressors have a response against infected macrophages superior to the response of CD8+ cells from patients on HAART. Our results suggest that the induction of a CD8+ T cell response effective against infected macrophages is an outcome to consider in rational vaccine design.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24942573      PMCID: PMC4136365          DOI: 10.1128/JVI.00860-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome.

Authors:  Damien Z Soghoian; Heiko Jessen; Michael Flanders; Kailan Sierra-Davidson; Sam Cutler; Thomas Pertel; Srinika Ranasinghe; Madelene Lindqvist; Isaiah Davis; Kimberly Lane; Jenna Rychert; Eric S Rosenberg; Alicja Piechocka-Trocha; Abraham L Brass; Jason M Brenchley; Bruce D Walker; Hendrik Streeck
Journal:  Sci Transl Med       Date:  2012-02-29       Impact factor: 17.956

3.  High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.

Authors:  A C McNeil; W L Shupert; C A Iyasere; C W Hallahan; J A Mican; R T Davey; M Connors
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

4.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.

Authors:  M R Betts; D R Ambrozak; D C Douek; S Bonhoeffer; J M Brenchley; J P Casazza; R A Koup; L J Picker
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.

Authors:  J P Casazza; M R Betts; L J Picker; R A Koup
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones.

Authors:  P J Norris; M Sumaroka; C Brander; H F Moffett; S L Boswell; T Nguyen; Y Sykulev; B D Walker; E S Rosenberg
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand.

Authors:  C F Hung; K F Hsu; W F Cheng; C Y Chai; L He; M Ling; T C Wu
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

Review 8.  Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir.

Authors:  Stefano Aquaro; Raffaele Caliò; Jan Balzarini; Maria Concetta Bellocchi; Enrico Garaci; Carlo Federico Perno
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

9.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.

Authors:  David C Goldstone; Valerie Ennis-Adeniran; Joseph J Hedden; Harriet C T Groom; Gillian I Rice; Evangelos Christodoulou; Philip A Walker; Geoff Kelly; Lesley F Haire; Melvyn W Yap; Luiz Pedro S de Carvalho; Jonathan P Stoye; Yanick J Crow; Ian A Taylor; Michelle Webb
Journal:  Nature       Date:  2011-11-06       Impact factor: 49.962

10.  Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages.

Authors:  Fransje A Koning; Caroline Goujon; Hélène Bauby; Michael H Malim
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

View more
  13 in total

1.  Short Communication: HIV Controller T Cells Effectively Inhibit Viral Replication in Alveolar Macrophages.

Authors:  Victoria E Walker-Sperling; Christian A Merlo; Robert W Buckheit; Allison Lambert; Patrick Tarwater; Greg D Kirk; M Bradley Drummond; Joel N Blankson
Journal:  AIDS Res Hum Retroviruses       Date:  2016-08-02       Impact factor: 2.205

2.  Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection.

Authors:  Heather A Prentice; Hailin Lu; Matthew A Price; Anatoli Kamali; Etienne Karita; Shabir Lakhi; Eduard J Sanders; Omu Anzala; Susan Allen; Paul A Goepfert; Eric Hunter; Jill Gilmour; Jianming Tang
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

3.  Interferon Alpha Enhances NK Cell Function and the Suppressive Capacity of HIV-Specific CD8+ T Cells.

Authors:  Abena K R Kwaa; Chloe A G Talana; Joel N Blankson
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

4.  Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors.

Authors:  David Shasha; Dan Karel; Olivia Angiuli; Adam Greenblatt; Musie Ghebremichael; Xu Yu; Filippos Porichis; Bruce D Walker
Journal:  J Leukoc Biol       Date:  2016-07-12       Impact factor: 4.962

5.  Nef Is Dispensable for Resistance of Simian Immunodeficiency Virus-Infected Macrophages to CD8+ T Cell Killing.

Authors:  Jennifer N Rainho; Mauricio A Martins; Francesc Cunyat; Ian T Watkins; David I Watkins; Mario Stevenson
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

6.  Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 Controller.

Authors:  Victoria E Walker-Sperling; Christopher W Pohlmeyer; Rebecca T Veenhuis; Megan May; Krystle A Luna; Allison R Kirkpatrick; Oliver Laeyendecker; Andrea L Cox; Mary Carrington; Justin R Bailey; Roberto C Arduino; Joel N Blankson
Journal:  EBioMedicine       Date:  2017-01-26       Impact factor: 8.143

7.  Counteracting Akt Activation by HIV Protease Inhibitors in Monocytes/Macrophages.

Authors:  Sébastien Pasquereau; Amit Kumar; Wasim Abbas; Georges Herbein
Journal:  Viruses       Date:  2018-04-13       Impact factor: 5.048

8.  Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system.

Authors:  Kiera L Clayton; David R Collins; Josh Lengieza; Musie Ghebremichael; Farokh Dotiwala; Judy Lieberman; Bruce D Walker
Journal:  Nat Immunol       Date:  2018-04-18       Impact factor: 25.606

9.  Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.

Authors:  Claudia R Avalos; Sarah L Price; Ellen R Forsyth; Julia N Pin; Erin N Shirk; Brandon T Bullock; Suzanne E Queen; Ming Li; Dane Gellerup; Shelby L O'Connor; M Christine Zink; Joseph L Mankowski; Lucio Gama; Janice E Clements
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

10.  Mechanisms of Abrupt Loss of Virus Control in a Cohort of Previous HIV Controllers.

Authors:  Miriam Rosás-Umbert; Anuska Llano; Rocío Bellido; Alex Olvera; Marta Ruiz-Riol; Muntsa Rocafort; Marco A Fernández; Patricia Cobarsi; Manel Crespo; Lucy Dorrell; Jorge Del Romero; José Alcami; Roger Paredes; Christian Brander; Beatriz Mothe
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.